Search Orphan Drug Designations and Approvals
-
Generic Name: | spartalizumab |
---|---|
Date Designated: | 10/18/2018 |
Orphan Designation: | Treatment of Stage IIB-IV melanoma |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 03/07/2024 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Novartis Pharmaceuticals Corporation One Health Plaza Office 337 A13.5B East Hanover, New Jersey 07936 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-